Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis
Blood · 2023
DOI: 10.1182/blood.2022016995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Ana Marín-Quílez und 18 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cáncer (CIC), Instituto de Biología Molecular y Celular del Cá…. Hauptthemen laut MEDLINE: Thrombocytopenia, UDPglucose 4-Epimerase. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Glycosylation is recognized as a key process for proper megakaryopoiesis and platelet formation. The enzyme uridine diphosphate (UDP)-galactose-4-epimerase, encoded by GALE, is involved in galactose metabolism and protein glycosylation. Here, we studied 3 patients from 2 unrelated families who showed lifelong severe thrombocytopenia, bleeding diathesis, mental retardation, mitral valve prolapse, and jaundice. Whole-exome sequencing revealed 4 variants that affect GALE, 3 of those previously unreported (Pedigree A, p.Lys78ValfsX32 and p.Thr150Met; Pedigree B, p.Val128Met; and p.Leu223Pro). Platelet phenotype analysis showed giant and/or grey platelets, impaired platelet aggregation, and severely reduced alpha and dense granule secretion. Enzymatic activity of the UDP-galactose-4-epimerase enzyme was severely decreased in all patients. Immunoblotting of platelet lysates revealed reduced GALE protein levels, a significant decrease in N-acetyl-lactosamine (LacNAc), showing a hypoglycosylation pattern, reduced surface expression of gylcoprotein Ibα-IX-V (GPIbα-IX-V) complex and mature β1 integrin, and increased apoptosis. In vitro studies performed with patients-derived megakaryocytes showed normal ploidy and maturation but decreased proplatelet formation because of the impaired glycosylation of the GPIbα and β1 integrin, and reduced externalization to megakaryocyte and platelet membranes. Altered distribution of filamin A and actin and delocalization of the von Willebrand factor were also shown. Overall, this study expands our knowledge of GALE-related thrombocytopenia and emphasizes the critical role of GALE in the physiological glycosylation of key proteins involved in platelet production and function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cáncer (CIC), Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Universidad de Salamanca-Centro Superior de Investigacio…
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.
- Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
- Centro de Diagnóstico de Enfermedades Moleculares, Universidad Autónoma de Madrid, CIBERER, IdIPAZ, Madrid, Spain.
- Servicio de Hematología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
- Servicio de Hematología, Hospital Virgen del Puerto, Plasencia, Spain.
ORCID-Profile: Ana Marín-Quílez, Christian Andrea Di Buduo, Lorena Díaz-Ajenjo, Vittorio Abbonante, Cristina Miguel-García, Sandra Santos-Mínguez, Inmaculada Serramito-Gómez, Pedro Ruiz-Sala, Jesús María Hernández-Rivas, Ignacio García-Tuñón, José Rivera, Alessandra Balduini, José María Bastida
Zitieren
APA
Marín-Quílez, A., Di Buduo, C. A., Díaz-Ajenjo, L., Abbonante, V., Vuelta, E., Soprano, P. M., Miguel-García, C., Santos-Mínguez, S., Serramito-Gómez, I., Ruiz-Sala, P., Peñarrubia, M. J., Pardal, E., Hernández-Rivas, J. M., González-Porras, J. R., García-Tuñón, I., Benito, R., Rivera, J., Balduini, A., & Bastida, J. M. (2023). Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood. https://doi.org/10.1182/blood.2022016995
Vancouver
Marín-Quílez A, Di Buduo CA, Díaz-Ajenjo L, Abbonante V, Vuelta E, Soprano PM, et al. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood. 2023. doi:10.1182/blood.2022016995
BibTeX
@article{MarnQulez2023,
author = {Marín-Quílez, Ana and Di Buduo, Christian Andrea and Díaz-Ajenjo, Lorena and Abbonante, Vittorio and Vuelta, Elena and Soprano, Paolo Maria and Miguel-García, Cristina and Santos-Mínguez, Sandra and Serramito-Gómez, Inmaculada and Ruiz-Sala, Pedro and Peñarrubia, María Jesús and Pardal, Emilia and Hernández-Rivas, Jesús María and González-Porras, José Ramón and García-Tuñón, Ignacio and Benito, Rocío and Rivera, José and Balduini, Alessandra and Bastida, José María},
title = {Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis},
journal = {Blood},
year = {2023},
doi = {10.1182/blood.2022016995}
}
EUVIMED